Genentech

Evrysdi has ‘real world impact’ on lives of babies with severe SMA, says Roche
Evrysdi has ‘real world impact’ on lives of babies with severe SMA, says Roche
Pharmaforum
Roche
Genentech
Evrysdi
SMA
Flag link:
Genentech and Novartis Win FDA Approval for Self-Injectable Form of Xolair
Genentech and Novartis Win FDA Approval for Self-Injectable Form of Xolair
BioSpace
Genentech
Novartis
FDA
Xolair
allergies
Flag link:
Genentech aims high with new diversity goals, including doubling hires and spending $1B with diverse suppliers
Genentech aims high with new diversity goals, including doubling hires and spending $1B with diverse suppliers
Fierce Pharma
Roche
Genentech
diversity
Flag link:
Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll
Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll
Fierce Pharma
Horizon Therapeutics
Roche
Genentech
AbbVie
Neurocrine
employee satisfaction
Flag link:
Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom
Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom
Endpoints
Roche
Genentech
M&A
GenMark Diagnostics
diagnostics
Flag link:
FDA Approves First Biologic for Rare, Debilitating Lung Disease
FDA Approves First Biologic for Rare, Debilitating Lung Disease
BioSpace
FDA
Roche
Genentech
Actemra
SSc-ILD
biologics
Flag link:
Genentech teams with academics for 10-year neuroscience R&D push
Genentech teams with academics for 10-year neuroscience R&D push
Fierce Biotech
Genentech
R&D
Neuroscience
Flag link:
Genentech Could Regain the Blindness-Related Disease Market with New Treatment
Genentech Could Regain the Blindness-Related Disease Market with New Treatment
BioSpace
Roche
Genentech
clinical trials
faricimab
age-related macular degeneration
nAMD
Flag link:
Why ipatasertib is not the Akt Astra wants to follow
Why ipatasertib is not the Akt Astra wants to follow
EP Vantage
Roche
Genentech
ipataserib
triple negative breast cancer
AstraZeneca
capivasertib
Flag link:
Roche and Genentech's latest AI collaborator raises $25M Series A to reinvent one of the oldest cancer targets
Roche and Genentech's latest AI collaborator raises $25M Series A to reinvent one of the oldest cancer targets
Endpoints
Roche
Genentech
artificial intelligence
machine learning
kinases
Reverie Labs
Flag link:
JPM Week: Genentech CEO says partnerships, speedier trials among pandemic's 'silver linings'
JPM Week: Genentech CEO says partnerships, speedier trials among pandemic's 'silver linings'
Fierce Pharma
Genentech
JPMHC 2021
partnerships
Flag link:
Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveiling
Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveiling
Fierce Biotech
Atalanta Therapeutics
Biogen
Genentech
F-Prime
neurodegenerative disease
Flag link:
Genentech Launches $1B+ RNA Collaboration with Ribometrix
Genentech Launches $1B+ RNA Collaboration with Ribometrix
Genetic Engineering News
Genentech
Roche
Ribometrix
small molecule drugs
drug discovery
R&D
Flag link:
Genentech pays Relay $75M for cancer drug, plans KRAS combo
Genentech pays Relay $75M for cancer drug, plans KRAS combo
Fierce Biotech
Genentech
Relay Therapeutics
Roche
KRAS inhibitors
Flag link:
A Genentech-partnered Vijay Pande favorite nabs $52M to advance an AI pipeline
A Genentech-partnered Vijay Pande favorite nabs $52M to advance an AI pipeline
Endpoints
Genesis
artificial intelligence
Genentech
Flag link:
Growing Opportunities – The Latest Job Expansions in the Life Sciences Industry
Growing Opportunities – The Latest Job Expansions in the Life Sciences Industry
BioSpace
hirings
Genentech
Revance Therapeutics
Novavax
Cold Chain Technologies
August Bioservices
Halda
Flag link:
FDA approves Roche’s Xofluza to prevent flu spreading in families
FDA approves Roche’s Xofluza to prevent flu spreading in families
Pharmaforum
FDA
Xofluza
Roche
Genentech
Flu
Flag link:
FDA begins review of Samsung Bioepis/Biogen’s Lucentis biosimilar
FDA begins review of Samsung Bioepis/Biogen’s Lucentis biosimilar
Pharmaforum
Novartis
Genentech
Lucentis
biosimilars
Samsung Bioepis
Biogen
FDA
Flag link:
Roche's James Sabry inks his second AI deal in back-to-back pacts — this time partnering Genentech with Stanford spinout Genesis Therapeutics
Roche's James Sabry inks his second AI deal in back-to-back pacts — this time partnering Genentech with Stanford spinout Genesis Therapeutics
Endpoints
Roche
Genentech
artificial intelligence
drug development
drug discovery
Genesis Therapeutics
Flag link:
FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies
FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies
Pharmaforum
Roche
Genentech
AbbVie
Venclexta
AML
clinical trials
FDA
Flag link:

Pages